查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1345330

全球帶狀皰疹疫苗市場（2023-2030）：按產品類型（Shingrix/Zostavax）/疫苗類型（重組疫苗/減毒疫苗）分類的規模、佔有率、成長分析和預測

Global Shingles Vaccine Market Size, Share, Growth Analysis, By Product(Shingrix, Zostavax), By Vaccine Type(Recombinant Vaccine, and Live Attenuated Vaccine) - Industry Forecast 2023-2030
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球帶狀皰疹疫苗市場規模預計將從2021年的35億美元成長到2022年的39.9億美元，預測期內年複合成長率為7.6%，到2030年將達到112.9億美元。

全球帶狀皰疹疫苗市場受到多種要素的推動，例如人口高齡化、人們對疫苗預防帶狀皰疹及相關合併的有效性的認知不斷提高以及各地區疫苗接種計劃的擴大等，預計未來幾年將出現強勁成長。市場對減毒活病毒疫苗和重組亞單位疫苗的需求穩定成長，後者因其安全性而受到青睞。此外，持續進行的旨在提高疫苗功效和可及性的研發，加上政府促進成人疫苗接種的努力，預計將刺激市場擴張。製藥行業的主要企業預計將專注於技術創新和戰略聯盟，以利用這一不斷擴大的市場機會。

全球帶狀皰疹疫苗市場的主要趨勢之一是日益關注人口高齡化的預防性醫療保健和免疫計劃。各國政府和醫療機構積極推動帶狀皰疹疫苗接種活動，疫苗接種率不斷提高。此外，疫苗技術的進步，例如開發更有效、更持久的疫苗，預計也將進一步推動市場成長。

本報告調查了全球帶狀皰疹疫苗市場，並提供了市場概況、影響市場的各種因素分析、技術和創新趨勢、法律和法規環境、市場規模趨勢和預測，以及按各個細分市場和地區進行的細分。我們總結了主要企業的細分、競爭形勢和概況。

目錄

  • 執行摘要
  • 調查方法
  • 母市場分析
    • 市場概況
    • 市場規模
    • 市場動態
  • 關鍵市場洞察
    • 技術分析
    • 價格分析
    • 供應鏈分析
    • 價值鏈分析
    • 市場生態系統
    • 知識產權分析
    • 貿易分析
    • 啟動分析
    • 原料分析
    • 創新矩陣
    • 管道產品分析
    • 宏觀經濟指標
    • 重點投資分析
    • 關鍵成功要素
    • 競爭程度
  • 市場動態及預測
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 課題
  • 法規狀況
  • 波特的分析
  • Skyquest 對未來顛覆的獨家見解
  • 全球帶狀皰疹疫苗市場：副產品
    • 市場概況
    • Shingrix
    • Zostavax
    • SKYZoster
  • 全球帶狀皰疹疫苗市場：按疫苗類型
    • 市場概況
    • 重組疫苗
    • 減毒活疫苗
  • 全球帶狀皰疹疫苗市場：按地區
    • 市場概況
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 競爭形勢
    • 前5名企業對比
    • 主要企業市場地位
    • 主要企業的招聘策略
    • 關鍵成功策略
    • 近期市場活動
    • 主要企業市場佔有率
  • 主要企業簡介
    • GlaxoSmithKline plc.
    • Merck & Co., Inc.
    • SK chemicals
    • Green Cross Corp
    • Geneone Life Science
    • Vaccitech
    • CanSinoBIO
簡介目錄
Product Code: SQMIG35I2203

Global Shingles Vaccine Market size was valued at USD 3.5 Billion in 2021 and is poised to grow from USD 3.99 Billion in 2022 to USD 11.29 Billion by 2030, growing at a CAGR of 7.6% in the forecast period (2023-2030).

The Global Shingles Vaccine Market is poised for robust growth in the coming years, driven by a combination of factors including an aging population, increasing awareness about the vaccine's effectiveness in preventing shingles and related complications, and expanding vaccination programs in various regions. The market is witnessing a steady rise in demand for both live attenuated and recombinant subunit shingles vaccines, with the latter gaining traction due to its safety profile. Furthermore, ongoing research and development efforts to improve vaccine efficacy and accessibility, coupled with government initiatives to promote adult vaccination, are anticipated to fuel market expansion. Key players in the pharmaceutical industry are expected to focus on innovation and strategic collaborations to capitalize on this growing market opportunity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Shingles Vaccine Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The shingles vaccine market is segmented based on Product, Vaccine Type, and Regional. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future. Based on Product the market is segmented as, Shingrix, Zostavax, SKYZoster. Based on Vaccine Type the market is segmented as, Recombinant Vaccine, Live Attenuated Vaccine. Based on Regional the market is segmented as, North America, Asia Pacific, Latin America, Middle East & Africa (MEA).

Driver:

The Global Shingles Vaccine Market is experiencing significant growth driven by several key factors. Firstly, an aging population worldwide has led to a higher susceptibility to shingles, creating a robust demand for preventive vaccines. Additionally, rising awareness about the importance of vaccination and the efficacy of shingles vaccines in reducing the severity and incidence of the disease is fueling market expansion. Furthermore, government initiatives and healthcare policies aimed at promoting adult immunization are bolstering market adoption. The introduction of innovative vaccines, such as recombinant subunit vaccines, is also contributing to market growth by offering improved efficacy and reduced side effects. Overall, the Global Shingles Vaccine Market is poised for continued expansion as the global healthcare community prioritizes prevention and immunization against shingles.

Restraint:

The Global Shingles Vaccine Market is currently experiencing several restraints that are impacting its growth trajectory. Firstly, the high cost of shingles vaccines has limited accessibility for a significant portion of the population, particularly in low- and middle-income countries, thus impeding market expansion. Secondly, the limited awareness about the severity of shingles and the benefits of vaccination among the general public is hindering the market's potential. Additionally, logistical challenges in vaccine distribution and storage, especially in remote areas, pose a significant barrier to market penetration. Lastly, regulatory hurdles and the lack of reimbursement policies in some regions are inhibiting market growth, making it crucial for stakeholders to address these constraints to unlock the full potential of the global shingles vaccine market.

Market Trends:

One key market trend in the Global Shingles Vaccine Market is the growing emphasis on preventive healthcare and immunization programs among aging populations. As the world's elderly population continues to expand, there is an increasing awareness of the importance of shingles vaccination in reducing the risk of this painful and debilitating condition. Governments and healthcare organizations are actively promoting shingles vaccination campaigns, leading to rising vaccine adoption rates. Additionally, advancements in vaccine technology, such as the development of more effective and longer-lasting vaccines, are anticipated to further drive market growth. Overall, the Global Shingles Vaccine Market is poised for significant expansion as a result of these demographic and technological factors.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Shingles Vaccine Market by Product
    • Market Overview
    • Shingrix
    • Zostavax
    • and SKYZoster
  • Global Shingles Vaccine Market by Vaccine Type
    • Market Overview
    • Recombinant Vaccine
    • and Live Attenuated Vaccine
  • Global Shingles Vaccine Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • GlaxoSmithKline plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • SK chemicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Green Cross Corp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Geneone Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vaccitech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CanSinoBIO
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments